Reallocate resources as last of the victims from Moderate Damage zone rescued, recovery operations commence in Severe Damage zone. Pressure on EMS systems continues due to ongoing patients with complications of ARS and difficulty responding in timely manner due to service area disruptions/access issues

Support care at assembly centers / shelters. Continue transporting victims to evacuation locations, which will decrease after first 10 days. Transport displaced persons with chronic illnesses to appropriate medical or special needs shelter facilities.

Healthcare Facility Response

III-15

Continually reassess survivors as scarce resource situation improves. Most will have ended crisis standards of care.
Anticipate many “concerned citizens” reaching facility requiring proper sorting from continued large numbers with ARS symptoms

Continue to screen and help monitor victims with ALC as well as obtaining laboratory results for clinical/epidemiologic data

III-17

Continue to request necessary supplies / staff from HMCC or EOC as directed

III-18

Provide support as possible to MC-Medical Care facilities, including alternate care facilities, and AC- Assembly Centers, to where people without immediate medical needs will be directed. Slow demobilization of these facilities over time

HMCC must maintain situational awareness, including daily incident action plans and communication with member hospitals and liaison with key stakeholders at EOC

III-28

Monitor healthcare system demand and balance loads across local and regional hospitals as possible by allocating available staff and resources to those areas with greatest need and prioritizing evacuation of patients from most-stressed facilities

III-29

Facilitate evacuation of facilities that have structural damage but were unable to evacuate earlier

III-30

Facilitate request and delivery of resources including personnel, SNS assets

III-31

Determine, with public health, transition of myeloid cytokines administration from AC/MC sites to clinics and other locations to continue daily treatment and contact with at-risk group 2-6Gy that was not able to be evacuated

III-32

Continually reassess standards of care in area and provide talking points to JPIC about when/where to seek care. Slow transition to normalization of medical care provision

Provide information as to who should and should not participate in long-term registry

III-34

Evacuate persons with likely 2-6Gy exposure to other jurisdictions for ongoing monitoring and myeloid cytokines treatment

III-35

Provide instructions and daily myeloid cytokines to the 2-6Gy exposure group that remains in the area and assure that similar clinics/centers are set up in neighboring jurisdictions (may start at AC and MC and transition to monitoring clinics set up according to jurisdictional plan with PH/EM)

III-36

Continue to triage patients for evacuation based on epidemiologic information and symptoms with addition of ALC as blood tests become more widely available

Recovery

III-37

Use ever-improving radiation and plume modeling and data to guide plans for recovery. Convene local groups along with outside radiation experts. Can define areas that will have NO radiation and remain useable and those with minimal risk.

III-38

Provide more detailed information about decontamination of property and vehicles to population

III-39

Provide easily understood information about relative risk for future malignancies and impact on property to those in fallout areas

III-40

Emphasize community resilience and neighbor helping neighbor.

III-41

Resume community functions, especially in unaffected areas

III-42

Increase staff and logistical support for long-term registry and for those to be followed for long-term cancer risk

III-43

Facilitate creation (with Federal agencies / VA system, others) of a network of integrated clinics that will follow and provide ongoing treatment for victims of the incident

III-44

Establish teams, timeline, and goals for medium- and long-term psychological support to help resilience.